Bioventus Inc Class A BVS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $13.63
- Day Range
- $13.39–13.79
- 52-Week Range
- $6.37–15.89
- Bid/Ask
- $13.20 / $13.55
- Shares Outstanding
- 68.31M
- Market Cap
- $918.70M
- Volume/Avg
- 509,320 / 664,087
Key Statistics
- Price/Earnings (Normalized)
- 14.56
- Price/Sales
- 1.61
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 950
- Website
- https://www.bioventus.com
Valuation
|
Metric
|
BVS
|
|---|---|
Price/Earnings (Normalized) | 14.56 |
Price/Book Value | 4.02 |
Price/Sales | 1.61 |
Price/Cash Flow | 9.35 |
Price/Earnings
BVS
Financial Strength
|
Metric
|
BVS
|
|---|---|
Quick Ratio | 1.10 |
Current Ratio | 1.69 |
Interest Coverage | 2.94 |
Quick Ratio
BVS
Profitability
|
Metric
|
BVS
|
|---|---|
Return on Assets (Normalized) | 9.73% |
Return on Equity (Normalized) | 35.80% |
Return on Invested Capital (Normalized) | 15.64% |
Return on Assets
BVS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|$cJkm% | LOCK|w!Y$$ | $167B | |||
| Medtronic PLC
MDT
| LOCK|W>F<?%% | LOCK|#HqH | $111B | |||
| Stryker Corp
SYK
| LOCK|@$GdC>#V | LOCK|^$ | $105B | |||
| Boston Scientific Corp
BSX
| LOCK|brW>G<s | LOCK|?<?j | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|@TRs$?^T | LOCK|WMyt | $49B | |||
| DexCom Inc
DXCM
| LOCK|VV<!Rl&x | LOCK|DDhm | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|#P<^!S | LOCK|<N$ | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Yh | LOCK|!% | $23B | |||
| Steris PLC
STE
| LOCK|%s<#dFY | LOCK|@mXY% | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|>N#$XfQ | LOCK|QL< | $17B |
United States